CD38 and type 2 diabetes mellitus: In agreement with these functional features, the presence ofanti-CD38 autoantibodies in type 2 diabetic patients was associated withsignificantly higher levels of fasting plasma C-peptide and insulin, ascompared with anti-CD38 negative subjects.